e-learning
resources
Vienna 2009
Monday, 14.09.2009
Pathobiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gene expression of angiogenic factors in pulmonary arteries from COPD
V. I. Peinado, M. M. Musri, M. Vives, M. Diez, S. Pizarro, E. Ferrer, R. Bastos, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain)
Source:
Annual Congress 2009 - Pathobiology of pulmonary hypertension
Session:
Pathobiology of pulmonary hypertension
Session type:
Oral Presentation
Number:
1590
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. I. Peinado, M. M. Musri, M. Vives, M. Diez, S. Pizarro, E. Ferrer, R. Bastos, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain). Gene expression of angiogenic factors in pulmonary arteries from COPD. Eur Respir J 2009; 34: Suppl. 53, 1590
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
microRNAs are deregulated in pulmonary arteries from COPD patients
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
The gene expression of the endothelial to mesenchymal transition-related transcription factor
slug
is increased in remodelled pulmonary arteries of COPD
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
Source: Eur Respir J 2008; 31: 135-139
Year: 2008
Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003
Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002
CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Cigarette smoking alters microRNA expression profiling and contributes to pulmonary artery remodeling via targeting connective tissue growth factor
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
microRNA-34a and microRNA 199a-5p in COPD and their control of HIF-1α expression in pulmonary vasucular endothelial cells
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
Source: Eur Respir Rev 2014; 23: 350-355
Year: 2014
Gene therapeutic approaches: from stem cell therapy to gene delivery
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept